Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind Placebo Controlled Trial Of [S,S]-Reboxetine In Patients With Chronic Painful Diabetic Peripheral Neuropathy.
Conditions
Interventions
Placebo
[S,S]-Reboxetine
Locations
56
United States
Pfizer Investigational Site
Anniston, Alabama, United States
Pfizer Investigational Site
Birmingham, Alabama, United States
Pfizer Investigational Site
Mission Viejo, California, United States
Pfizer Investigational Site
Denver, Colorado, United States
Pfizer Investigational Site
New Britain, Connecticut, United States
Pfizer Investigational Site
Waterbury, Connecticut, United States
Start Date
December 1, 2007
Primary Completion Date
November 1, 2008
Completion Date
November 1, 2008
Last Updated
December 13, 2019
NCT07425275
NCT06483620
NCT03594344
NCT05683106
NCT06670430
NCT06264427
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions